Lakewood-Amedex Biotherapeutics
LABT----
Forecast & RatingOnly 1 analyst currently covers Lakewood-Amedex Biotherapeutics (LABT.US), with a price target of $12.00. The sample is very small, so treat this as a reference only. Data as of Jun 23, 2026; this does not constitute investment advice.
Jun 23, 2026Price forecast
$12.00354.55%
Forecast & Rating-
0analysts
Target price forecast
Forecast baselineJul 23, 2026
Forecast met0.0%
Stock price$2.64
Average forecast price$12.0
Highest forecast price$12
Lowest forecast price$12
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.